A Novel Pathogenic Variant in Fibroblast Growth Factor 23 outside the Furin-Recognizing RXXR Motif in an Autosomal Dominant Hypophosphatemic Rickets Patient
Hiroyuki Tanaka(The University of Tokyo), Sachiko Kitanaka(The University of Tokyo), Nobuaki Ito(University of Tokyo Hospital), Mayuko Tamura(The University of Tokyo), Mirai Muto(Japanese Red Cross Kumamoto Hospital), Yuka Kinoshita(University of Tokyo Hospital), Akira Oka
Cited by 7
Related Papers
Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice.
|PubMed|2000|334
Purification and characterization of human granulocyte colony‐stimulating factor (G‐CSF).
|The EMBO Journal|1986|243
Multiple candidate gene analysis identifies α-synuclein as a susceptibility gene for sporadic Parkinson's disease
|Human Molecular Genetics|2006|207
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
|Calcified Tissue International|2019|160
X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment
|Endocrine Reviews|2018|148